Tharimmune Inc (THAR)
3.35
+0.01
(+0.30%)
USD |
NASDAQ |
Jun 14, 16:00
3.77
+0.42
(+12.54%)
Pre-Market: 07:59
Tharimmune Free Cash Flow: -6.661M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.661M |
| December 31, 2023 | -7.300M |
| September 30, 2023 | -6.777M |
| June 30, 2023 | -7.417M |
| March 31, 2023 | -7.294M |
| Date | Value |
|---|---|
| December 31, 2022 | -6.558M |
| September 30, 2022 | -5.673M |
| June 30, 2022 | -4.441M |
| March 31, 2022 | -3.322M |
| December 31, 2021 | -1.086M |
Free Cash Flow Range, Past 5 Years
-7.417M
Minimum
Jun 2023
-1.086M
Maximum
Dec 2021
-5.653M
Average
-6.609M
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals Inc | 147.91M |
| Mirum Pharmaceuticals Inc | -42.04M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.825M |
| Cash from Financing (Quarterly) | 0.3171M |
| Free Cash Flow Per Share (Quarterly) | -3.604 |
| Free Cash Flow Yield | -481.3% |